Monocyte subtype counts are associated with 10-year cardiovascular disease risk as determined by the Framingham Risk Score among subjects of the LIFE-Adult study
Table 1
Characteristics of 690 individuals from LIFE-Adult with Cytomics assessment and grouped by calculated Framingham Risk Score: Low (<10%), moderate (10%—<20%) and high risk (≥20%) groups.